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The aim of this study was to evaluate the antioxidant, the anti-inflammatory, and the antitumoral activities of the aqueous ethanolic
extract from Phoenix dactylifera L. parthenocarpic dates. The antioxidant activity was carried using DPPH radical scavenging
activity. The result showed that parthenocarpic dates had strongly scavenging activity on DPPH reaching 94% with an IC
50
value
of 0.15 ± 0.011mg/mL (p < 0.05). The anti-inflammatory potential was determined by the inhibitory effect of the aqueous ethanolic
extract on phospholipase A
2
activity as well as on carrageenan-induced paw oedema in mice. The in vitro study showed that the
extract inhibited the phospholipase A
2
activity with an IC
50
value of 130 𝜇g/mL and the in vivo study showed a significantly decrease
in the paw oedema after 1 h compared to the control group. Finally, the antiproliferative activity of the aqueous ethanolic extract
was assessed byMTT test against MCF-7 andMDA-MB-231 cancer cell lines.This extract was effective in inhibiting MDA-MB-231
and MCF-7 cancer cells growth with IC
50
values of 8 and 18mg/mL, respectively, after 72 h treatment. These results confirm the
ethnopharmacological significance of Phoenix dactylifera L. parthenocarpic dates, which could add support for its pharmaceutical
use.
1. Introduction
Oxidative stress is an important risk factor in the patho-
genesis of numerous chronic diseases. Free radicals and
other reactive oxygen species can adversely affect various
important classes of biological molecules, such as protein,
deoxyribonucleic acid (DNA), and lipids causing oxidative
deterioration of biomolecules [1]. This damage can lead
to various human diseases, especially aging, heart disease,
stroke, arteriosclerosis, diabetes, cancer, and inflammation
[1].
Inflammation is considered as a primary physiologic
defense mechanism against various factors such as infec-
tion, burn, toxic chemicals, allergens, and other stimuli [2].
There are many components of an inflammatory response
that participate in the associated symptoms and harmful
effects to tissues. It involves a complex web of intracel-
lular cytokine signals, which activate monocytes and/or
macrophages releasing a variety of inflammatory mediators
such as prostaglandins, platelet-activating factor (PAF), and
arachidonic acid derivatives, which can originate locally or
from cells that infiltrate in the site of inflammation [3]. Actu-
ally, nonsteroidal anti-inflammatory drugs (NSAIDs) are the
most clinically important medicine used for the treatment
of inflammation by inhibiting the cyclooxygenase (COX)
pathway of arachidonic acid metabolism which produces
prostaglandins [4]. Nevertheless, these drugs are limited
in their effectiveness and cannot regulate the production
of leukotrienes or PAF that continues to cause inflamma-
tion. Moreover, cyclooxygenase inhibitors could favor the
appearance of thrombosis or renovascular hypertension in
patients predisposed to these conditions [5].The inhibition of
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phospholipase A
2
(PLA
2
) may serve as a primary regulatory
role in the development of inflammatory disorders and
could deplete the sources of arachidonic acid and, therefore,
its downstream metabolites and PAF, thus constituting an
important strategy for the management of inflammatory
disorders.
Chronic inflammation increases the risk of resistance and
tumor recurrence, such as brain and breast cancer, indicating
that eliminating inflammation may represent a valid strategy
for cancer prevention and therapy [6]. Despite the advances
in the field of anticancer drug discovery, the statistics are
noteworthy; in 2012, 14.1 millions new cases of cancer were
diagnosed worldwide, with 8.2 millions deaths [7]. Thus,
there is still a necessity for the development of new therapies
and the tumor microenvironment is an important source of
multiple targets for cancer therapy, including oxidative stress
and inflammation [7].
Nature has been a source of medicinal products for
millennia, going along with the history of humanity. In
chemotherapy field, around 75% of the anticancer agents
used nowadays are derived from natural products of different
origins, and plants are an important source of new promising
therapies [7]. Phoenix dactylifera L. (date palm) is an ancient
plant used in folk medicine for the treatment of various
diseases and disorders [2]. Dates and their constituents act
as potent antioxidant, anti-inflammatory, and antitumoral
and provide a suitable alternative therapy in various diseases
cure [2]. According to the Inter Professional Fruits Group
(GIFruits), dates production in Tunisia reached 246.000
tons in 2015, 40% of which is disposed or recycled as
animal feed [8]. These are mainly dates attacked by pests,
fermented and parthenocarpic dates (Sish). The previous
study has shown that the aqueous ethanolic extract from
P. dactylifera parthenocarpic dates contains several bioac-
tive components such as p-coumaric acid hexose, rosma-
dial, quercetin, quercetin-3,7-di-O-glucoside, and ganoder-
mic acid [8]. Therefore, the objective of this study was
to evaluate the antioxidant, the anti-inflammatory, and the
antiproliferative activities of the aqueous ethanolic extract
from P. dactylifera parthenocarpic dates.
2. Materials and Methods
2.1. Extract Preparation. The aqueous ethanolic extract from
P. dactylifera parthenocarpic date was prepared using pre-
viously described protocol [8]. Briefly, the dried powdered
of healthy palm parthenocarpic dates (15 g) was macerated
in 100mL 71% ethanol solution (pH = 8.5) for 24 h at 59∘C
under stirring condition. The hydroalcoholic crude extract
was filtered and concentrated under reduced pressure. The
extract was dissolved in distilled water and then preserved at
4∘C.
2.2. Storage Conditions. The dry extract was introduced into
glass bottles protected (amber) from light and stored at - 20∘C
according to Del-Toro-Sánchez et al. [9]. Then, the extract
stabilitywasmeasured before the use of the aqueous ethanolic
extract by determining total phenols, flavonoids, and tannins
contents as described in the previously study [8].
2.3. Antioxidant Activity: DPPH Radical Scavenging Activity.
DPPH radical scavenging activity of the aqueous ethanolic
extract from P. dactylifera parthenocarpic dates was deter-
mined according to the method of Kim et al. [10].The sample
stock solution (100mg of dry extract/mL) was diluted to
final concentrations of 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.45,
and 0.6mg of dry extract/mL in ethanol. A total of 0.5mL
of 30mM DPPH ethanol solution was added to 0.5mL of
sample solution at different concentrations and allowed to
react at room temperature. After 30min, the absorbance (A)
was measured at 520 nm.
The ability to scavenge the DPPH radical was calculated
using the following equation:
Radical Scakenging capacity (RSC, %)
= 1 − [(Asample − Asample blank)
Acontrol
] x 100 (1)
where Acontrol is the absorbance of the control (DPPH
solution without sample), Asample is the absorbance of the test
sample (DPPH solution plus test sample), and Asample blank is
the absorbance of the sample only (sample without DPPH
solution).
Results of DPPH radical scavenging were presented by
IC
50
value, defined as the concentration of extract which
required reducing DPPH radicals by 50%.
2.4. Anti-Inflammatory Activity
2.4.1. Animals and Experimental Design. Male albino mice of
20-25 g body masses, obtained from the Veterinary Research
Institute (Sfax, Tunisia) and maintained under standard
laboratory conditions (temperature 22 ± 2∘C on 12 h light-
dark cycle), were used in this study. Throughout the exper-
imental period, the animals had ad libitum access to food
and water. The experimental protocol was approved by the
Medical EthicsCommittee for theCare andUse of Laboratory
Animals of the Pasteur Institute of Tunis (approval number:
FST/LNFP/Pro 152012) and performed according to the
European convention for the protection of living animals
used in scientific investigations [11].
2.4.2. In Vitro Study: Phospholipase A2 Inhibition Assay.
Phospholipase inhibition assay was performed using
PLA
2
/extract preincubation method during 1 h at room
temperature in the absence of substrate [12]. Preincubation
medium consisted of 10 units of PLA
2
and the aqueous
ethanolic extract from P. dactylifera parthenocarpic dates
with varying concentrations from 0 to 200𝜇g of dry
extract/mL. A control sample was prepared accordingly
without the aqueous ethanolic extract. The residual activity
was measured titrimetrically at pH = 8 and 40∘C with a
pH-stat (Metrohm, Buchs, Switzerland), using 0.5% (m/v)
egg yolk phosphatidylcholine as a substrate in 30mL of
150mM NaCl, 4mM sodium taurodeoxycholate (NaTDC),
and 8mM CaCl
2
. The results were expressed as residual
activity compared with the control. IC
50
value, defined as
the sample concentration (𝜇g/mL) at which 50% inhibition
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of the enzyme activity occurs, was calculated from the
graph plotting enzyme residual activity against sample
concentration. All tests were carried out for three sample
replications and the results were averaged.
2.4.3. In Vivo Study: Carrageenan-InducedMice PawOedema.
Mice were divided into three groups of six animals. Group
1 was served as a negative control and received saline
water without the extract (solution of 0.90% (m/v) NaCl).
Prior to the induction of the oedema, group 2 was injected
intraperitoneally with the aqueous ethanolic extract from
parthenocarpic dates (200mg/kg), respectively. Group 3 was
administered by an intraperitoneal injection of indomethacin
(50mg/kg) as a positive control. All drugswere administrated
30min before the injection of carrageenan. Oedema was
induced by injecting 0.3mL of 2% carrageenan subcuta-
neously into the subplantar region of the left hind paw [13].
The paw oedema thickness was measured by using a digi-
tal micrometer (MT-045B; Shangai Metal Great Tools Co.,
Shangai, China) immediately before carrageenan injection
and 1, 2, 3, and 4 h after carrageenan injection. Percentages
of inhibition of inflammation were obtained for each group
using the following ratio:
Inhibition (%) = [(Vt − V0)control − (Vt − V0)treated]
× 100(Vt − V0)control
(2)
where Vt is the average volume for each group at different
hours after treatment andV
0
are the average volume obtained
for each group before any treatment.
2.5. Antitumoral Activity
2.5.1. Cell Line andCulture Conditions. Thehuman tumor cell
lines MDA-MB-231 (breast carcinoma) and MCF-7 (breast
adenocarcinoma) were a kind gift of Dr. Khadija Essafi-
Benkhadir, Institute Pasteur Tunis, Tunisia. Tumor cells
were routinely maintained in Dulbecco’s modified Eagle’s
minimum essential medium (DMEM) supplemented with
10% heat inactivated fetal bovine serum, 2mM glutamine,
1% penicillin, and streptomycin at 37∘C in a humidified
atmosphere containing 5% CO
2
.
2.5.2. Cell Viability Assay. The effect of the aqueous ethanolic
extract from P. dactylifera parthenocarpic dates on the viabil-
ity of MDA-MB-231 and MCF-7 cells was assessed using the
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) method according to Boulaaba et al. [14]. Tumor
cells at optimal density were seeded in 96-well microplates
(Nunc 96-Well Microplates-Thermo Scientific) and incu-
bated overnight at 37∘C under 5% CO
2
to allow them
to attach. Aqueous ethanolic extract from P. dactylifera
parthenocarpic dates at different concentrations (1 to 100mg
of dry extract/mL) was added to adhered cells and incubated
for 24 h and 72 h. After the indicated time, MTT solution
was added and cells were incubated for a further 4 h. The
solutions were aspirated out, and DMSO was added to solu-
bilize the formazan crystals within metabolically viable cells.
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Figure 1: Antioxidant activities of the aqueous ethanolic extract
from Phoenix dactylifera parthenocarpic dates. Differences in
antioxidant activity were estimated by one-way analyses of variance
(ANOVA) and unpaired Student's t-test compared to the control (∗p<0.05 and ∗∗p <0.01).
Absorbancewas determined by amicroplate reader at 560 nm
on a multidetection microplate reader (Thermo Labsystems,
Franklin, MA, USA). Results were evaluated by comparing
the absorbance of the treated cells with the absorbance of
wells containing cell treated by the solvent control. Conven-
tionally, cells incubated onlywith themediumand the solvent
were considered the control with 100% viability.
All experiments were performed at least twice in tripli-
cate. The concentration of the substance required for 50%
growth inhibition (IC
50
value) was estimated as that resulting
in 50% decrease in absorbance as compared to control
incubated simultaneously without test substances.
2.6. Statistical Analysis. Values were expressed as themean of
triplicate analysis of the samples (n = 3) standard deviation (±
SD). Statistical analysis was performed by one-way analyses
of variance (ANOVA) and unpaired Student's t-test was used
to determine significant differences in hyperglycemia and
where appropriate. Differences were considered statistically
significant if p < 0.05.
3. Results and Discussion
3.1. DPPHRadical Scavenging Activity. Theantioxidant activ-
ity was defined as the mean of free radical scavenging
capacity. This activity was measured using the 1,1-diphenyl-
2-picrylhydrazyl free radical (DPPH), which is a stable free
radical and in the presence of the total extract; it was
scavenged. In this study, the antioxidant effect of the aqueous
ethanolic extract from P. dactylifera parthenocarpic dates was
examined by DPPH radical scavenging capacity.The aqueous
ethanolic extract showed a potential antioxidant activity in
DPPHradical scavengingwith an IC
50
value of 0.15± 0.011mg
of dry extract/mL (p< 0.05) (Figure 1).The aqueous ethanolic
extract was shown to scavenge 94% of superoxide radicals
at 0.6 ± 0.03mg/mL (p < 0.05). This extract had a strong
free radical scavenging ability compared to the aqueous
date extract (0.8mg/mL) [15] based on the same method.
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Moreover, the aqueous ethanolic extract fromparthenocarpic
dates exhibited high DPPH scavenging activity compared
with Diplotaxis simplex extract (0.4mg/mL) [16] and Aloe
vera leaf (0.635mg/mL) [12]. These results were in line with
those of Mansouri et al. [17] and Hasan et al. [18] who
reported that date fruits exhibited potent DPPH scavenging
capacities.
Fruits contain different antioxidant compounds. There-
fore, measuring the antioxidant capacity of each compound
individually becomes very difficult. Several methods have
been developed to estimate the antioxidant potential of
different plant materials. Usually, these methods measure
the ability of antioxidants to scavenge specific radicals. The
present study showed that the aqueous ethanolic extract
had significant antioxidant activity toward the DPPH free
radical assay. The antioxidant activity could be due to the
high content of the phytochemical compounds of the aqueous
ethanolic extract from parthenocarpic dates. In fact, the
content of total phenols was estimated at 513 ± 2mg of GAE/g
of the dry extract [8] and the extractmaintains approximately
up to 95% stability in phenolic content when stored at −20∘C
in the dark. Moreover, the physicochemical results by liquid
chromatography-tandem mass spectrometry (LC–MS/MS)
analysis demonstrated that the aqueous ethanolic extract
from P. dactylifera parthenocarpic dates contain several
bioactive components acting as antioxidants, such as p-
coumaric acid hexose, rosmadial, quercetin, and ganoderenic
acid [8]. The antioxidant activity of phenolic compounds is a
result of their redox properties, which can play an important
role in absorbing and neutralizing free radicals [19].
Reactive free radicals, such as superoxide anion radical,
hydroxyl radical, and hydrogen peroxide, have been impli-
cated in the development of many diseases such as can-
cer, coronary heart disease, autoimmune disease, diabetes,
sclerosis, cataracts, and chronic inflammation. According to
the important activity on free radical scavenging, the anti-
inflammatory effect of the aqueous ethanolic extract from P.
dactylifera parthenocarpic dates was investigated in vitro and
in vivo.
3.2. Evaluation of the Anti-Inflammatory Activity
3.2.1. In Vitro Study: Inhibition of Phospholipase A2 Activity.
Phospholipase A
2
is a class of enzyme that catalyzes the
hydrolysis of membrane phospholipids releasing arachidonic
acid, which serves as a substrate for proinflammatory medi-
ators, such as prostaglandins and leukotrienes. The design of
specific inhibitors for PLA
2
might help in the development of
new anti-inflammatory drugs.
In this study, the aqueous ethanolic extract was evaluated
for their inhibitory effect on the proinflammatory PLA
2
activity. The in vitro assay results revealed that the aqueous
ethanolic extract showed a significant inhibitory activity
against PLA
2
activity depending on the doses of the extract
(Figure 2). At a concentration of 130 𝜇g of dry extract/mL,
the P. dactylifera extract reduced by 50% the activity of
the enzyme in a highly significant manner (p < 0.001).
This extract exhibited a potent inhibition of PLA
2
than the
Aloe vera L. extract (IC
50
= 0.22mg/mL) [12], Diplotaxis
0
20
40
60
80
100
Re
sid
ua
l a
ct
iv
ity
 (%
) 
50 100 150 2000
Concentration (g/mL)
∗
∗
∗∗
∗∗
∗∗∗
Figure 2: Effect of the aqueous ethanolic extract from Phoenix
dactylifera parthenocarpic dates on phospholipase A
2
activity (∗p<0.05, ∗∗p <0.01, and ∗∗∗ p < 0.001).
simplex extract (IC50 = 2.97mg/mL) [16], and Polygonum
multiflorum extract (IC
50
= 680 𝜇g/mL) [20]. The PLA
2
inhibition could be explained by the richness of the aqueous
ethanolic extract in phenolic compounds, such as flavonoids,
which are able to inhibit key enzymes related to inflammation
process [12]. Besides, molecular modeling studies suggested
that phenolic hydroxyls are linked to the amino acidAsp 49 of
PLA
2
and influence the capacity of this residue to participate
in the coordination of the calcium atom, that is, essential to
the catalytic activity [21].
3.2.2. In Vivo Study: Carrageenan-InducedMice PawOedema.
The carrageenan-induced paw oedema is a well-known acute
model of inflammation that is widely used for screening
novel anti-inflammatory compounds. Immediately after car-
rageenan injection, there is a cascade of mediators’ release, as
histamine, serotonin, bradykinin, and PLA
2
.Thesemediators
promote an increase in vascular permeability and signal for
arachidonate metabolites and nitric oxide release, until the
6th hour.
Before induction of the inflammatory response, mice
paw thickness was found to be 0.20 ± 0.01 cm (p < 0.05).
The phlogistic agent when injected locally into the rat hind
paw of the control group induced a severe inflammatory
reaction, characterized by an increase in paw thickness up
to 0.27 ± 0.01 cm (p < 0.05) and 0.32 ± 0.01 cm (p <
0.01) after 1 and 4 h, respectively (Table 1). The maximum
peak was observed 3 h after injection when the mice paw
thickness was found to be 0.36 ± 0.01 cm (p < 0.05) (Table 1).
The treatment with the standard indomethacin significantly
inhibited the paw thickness of carrageenan-induced mice,
which reached 0.26 ± 0.01 cm and 0.22 ± 0.02 cm after
3 h and 4 h, respectively (Table 1). As shown in Table 1,
the aqueous ethanolic extract from parthenocarpic dates
showed significant anti-inflammatory activity when admin-
istered intraperitoneally, in the carrageenan-induced rat paw
oedema test.The paw thickness of carrageenan-inducedmice
showed a decrease after 1 h (0.22 ± 0.02 cm (p < 0.05))
stronger than the indomethacin effect (0.24 ± 0.01 cm (p <
0.05)).Thepercentage of inhibition of oedema by the aqueous
ethanolic extract, 3 h after carrageenan injection, ranged from
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Table 1: Anti-inflammatory effect of the intraperitoneal administration of the aqueous ethanolic extract from Phoenixdactylifera
parthenocarpic dates in Carrageenan-induced mice paw oedema test.
Treatment Paw thickness (cm) Inhibition (%)
1 h 2 h 3 h 4 h 1 h 2 h 3 h 4 h
Control 0.27 ± 0.01∗ 0.32 ± 0.02 ∗∗ 0.36 ± 0.01∗ 0.32 ± 0.01 ∗∗ - - - -
Indomethacin 0.26 ± 0.01∗ 0.26 ± 0.01ns 0.24 ± 0.01 ∗∗ 0.22 ± 0.02∗ 14.28 50 75 83.33
Extract 0.22 ± 0.02∗ 0.24 ± 0.02∗ 0.21 ± 0.01∗ 0.2 ± 0.02∗ 71.2 66.66 93.75 100
Values are expressed as mean ± SD (n=6 animals).
∗: differences were considered statistically significant if p <0.05.
∗∗: differences were considered statistically significant if p <0.01.
ns: not significant.
93% to 100%, whereas the reference drug produced 75% of
inhibition after 3 h (Table 1). These results confirmed the
anti-inflammatory activity of the aqueous ethanolic extract
from P. dactylifera parthenocarpic dates, which could lend
support for its pharmaceutical use. Similar results were
observed with genus Cystoseira extract [1] and Diplotaxis
simplex extract [16] which reduced the paw oedema in mice,
after carrageenan injection. Moreover, Mohamed and Al-
Okbi demonstrated that oral administration of methanolic
or aqueous extracts of edible portion of P. dactylifera dates
suppressed the inflammation in the foot of adjuvant arthritis
rats [22].
Carrageenan rat paw oedema test produced an acute
inflammation that results from the sequential action of
several mediators. Histamine and serotonin were mainly
released during first 1.5 h after carrageenan injection, kinin
was released until 2.5 h, and at the last step, inflammation
was continued until 5 h by prostaglandins. The aqueous
ethanolic extract inhibited the PLA
2
enzymatic activity in
the first phase of inflammation (arachidonate metabolites
generation). The bioactive compounds, especially quercetin,
present in the aqueous ethanolic extract can be the respon-
sible for the anti-inflammatory activity [23]. In addition, the
antioxidant potential observed in P. dactylifera extract can be
also contributed for reducing inflammation.Thus, the potent
anti-inflammatory activity of P. dactylifera parthenocarpic
dates extract may be related to cumulative effects of different
active compounds to reduce the synthesis, release, and action
of prostaglandins or free radicals.
Increasing scientific evidence shows that polyphenols are
good antioxidants and are effective in preventing inflamma-
tory diseases and can also be used as chemopreventive agents
for cancer. These molecules might act as cancer blocking
agents, preventing initiation of the carcinogenic process and
as cancer suppressing agents, inhibiting cancer promotion
and progression [1]. Herein, we evaluated the anticancer
effects of the aqueous extract on human breast cancer (MDA-
MB-231 and MCF-7) cells in vitro.
3.3. Evaluation of the Antitumoral Activity. Breast cancer
is the most common and leading cause of cancer-related
mortality among women globally [24]. In 2012, more than
464,000 new cases were diagnosed with breast cancer in
the European Union (EU) and in the United States of
America (USA) [24]. It was estimated that there will be
249.260 new cases of female breast carcinoma in the year
2016 [24]. This has led to an increased interest and active
search for novel anticancer agents from natural products.
In the present study, we attempt to evaluate the anticancer
effects of the aqueous ethanolic extract from P. dactylifera
parthenocarpic dates on human breast carcinoma (MDA-
MB-231) and adenocarcinoma (MCF-7) cells.
The effect of different concentrations (1 to 100mg of dry
extract/mL) of the aqueous ethanolic extract on tumor cell
viability using the MTT method was assessed (Figure 3(a)).
After 24 h incubation ofMDA-MB-231 cells with the aqueous
ethanolic extract, no significant inhibition of cell growth
was observed at (1-25mg/mL). However, results showed that
the cytotoxic effect appeared at high concentrations (50
and 100mg/mL), when cell viability decreased by 43.66%
and 78.48%, respectively (Figure 3(a)). Similarly, results have
been observed after treatment of MCF-7 with the aqueous
ethanolic extract for 24 h. MCF-7 cells growth inhibition and
signs of cytotoxicity were not significantly apparent until a
concentration of 25mg/mL (80% of cell viability). Then cell
viability diminished with the dose of 50 and 100mg/mL to
43.34% and 71.67%, respectively (Figure 3(a)). Interestingly,
the viability of both MDA-MB-231 and MCF-7 tumor cells
decreased drastically in a dose-dependent manner after 72 h
of treatment with aqueous ethanolic extract with respective
IC
50
values of 8 ± 0.02mg/mL (p < 0.01) and 18 ± 0.02mg/mL
(p < 0.01) (Figure 3(b)).
MDA-MB-231 and MCF-7 cells viability inhibition was
more pronounced after 72 h of incubation as compared
to 24 h of aqueous ethanolic extract treatment. This result
suggests that the inhibition of cell viability may be related
to the suppression of proliferation rather than to any cyto-
toxic or cytolytic effects. This activity might be due to the
presence of specific compounds in parthenocarpic dates,
like flavonoids glucosides (quercetin), which are known by
their cancer chemoprotective attributes [25]. In this context,
Rahmani et al. [26] confirmed the therapeutic effects of P.
dactylifera dates in preventing against cancer are due to its
richness in polyphenolic compounds. In addition, previous
studies showed that polyphenolic compounds affect cancer
cell growth by inducing apoptosis in many cell lines related
to breast cancer [24]. In addition, the anticancer effect
of the methanolic extract of Ajwa date on human breast
adenocarcinoma (MCF-7) cells was evaluated in vitro. MCF7
cells treated with concentrations (5, 10, 15, 20, and 25mg/mL)
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Figure 3: Effect of the aqueous ethanolic extract from Phoenix dactylifera parthenocarpic dates onMDA-MB-231 andMCF-7 cancer cell lines
viability at 24 h (a) and 72 h (b). Differences between selected groups were compared to nonparametric analysis of variance (ANOVA) with
Bonferroni post hoc multiple comparison test compared to the control (∗p <0.05 and ∗∗p <0.01).
of methanolic Ajwa date extract inhibited the growth and the
proliferation of its cells by inducing cell cycle arrest. It also
induced MCF7 cell death via apoptosis in a dose and time-
dependent manner by the activation and changes in genetic
expression associated with apoptosis [24].
One important aspect of carcinogenesis is recognized
to be the involvement of inflammation. Many studies have
been conducted to treat cancers by using various anti-
inflammatory agents. In fact, the use of anti-inflammatory
agents can alter cancer cell and its microenvironment, poten-
tially increasing apoptosis, and decreasing migration. Inter-
estingly, natural phenolics could exhibit anti-inflammatory
properties and also a possible role in the inhibition of cancer
development through a number of basic cellular mechanisms
[27].
4. Conclusion
P. dactylifera plays an important role in social, economic,
and ecological Tunisian sectors. Some date palms produce
parthenocarpic fruit named Sish. This study revealed that
the aqueous ethanolic extract from P. dactylifera partheno-
carpic dates provides a strong antioxidant activity associated
with an interesting anti-inflammatory activity and significant
antiproliferative activity against MDA-MB-231 and MCF-7
cancer cell lines. The antitumoral effect of aqueous ethano-
lic extract could be attributed to a single molecule or to
the synergic activity of several components of the total
extract.
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(i) The aqueous ethanolic extract showed a potential antiox-
idant activity. (ii) The in vitro study showed that the extract
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2
. (iii)The in vivo study showed
a significantly decrease in the paw oedema in mice. (iv) The
extract was effective in inhibiting MDA-MB-231 and MCF-7
cancer cell growth.
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